Max Planck Society for the Advancement of Science EV

Grantee Website München, Germany
Purpose
to define a biosignature for increased risk of developing TB to: (i) accelerate clinical vaccine trials, (ii) facilitate design of preventive drug therapy and (iii) provide guidelines for improved diagnosis.
Division
Global Health
Year Awarded
2012
Region Served
GLOBAL
Committed Amount
$1,762,708
Grant Topic
Tuberculosis
Duration (Months)
50
Grantee Location
München, Germany

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.